4.8 Article

The Card1 nuclease provides defence during type III CRISPR immunity

期刊

NATURE
卷 590, 期 7847, 页码 -

出版社

NATURE PORTFOLIO
DOI: 10.1038/s41586-021-03206-x

关键词

-

资金

  1. Boehringer Ingelheim Fonds PhD fellowship
  2. Burroughs Wellcome Fund PATH Award
  3. National Institutes of Health (NIH) Director's Pioneer Award [DP1GM128184]
  4. Geoffrey Beene Cancer Research Center
  5. NIH [GM129430]
  6. Memorial Sloan Kettering Cancer Center Core Grant [P30CA008748]
  7. US NIH [NIGMS P30 GM124165]
  8. NIH-ORIP HEI grant [S10 RR029205]
  9. DOE Office of Science [DE-AC02-06CH11357]

向作者/读者索取更多资源

The type III CRISPR system utilizes CARF domain proteins to provide immune defense, with Card1 serving as an activated nucleic acid enzyme that induces infected hosts into dormancy to provide immunity by cleaving single-stranded RNA and DNA. This strategy highlights the diversity of methods used by CRISPR systems in providing immune defense.
In the type III CRISPR-Cas immune response of prokaryotes, infection triggers the production of cyclic oligoadenylates that bind and activate proteins that contain a CARF domain(1,2). Many type III loci are associated with proteins in which the CRISPR-associated Rossman fold (CARF) domain is fused to a restriction endonuclease-like domain(3,4). However, with the exception of the well-characterized Csm6 and Csx1 ribonucleases(5,6), whether and how these inducible effectors provide defence is not known. Here we investigated a type III CRISPR accessory protein, which we name cyclic-oligoadenylate-activated single-stranded ribonuclease and single-stranded deoxyribonuclease 1 (Card1). Card1 forms a symmetrical dimer that has a large central cavity between its CRISPR-associated Rossmann fold and restriction endonuclease domains that binds cyclic tetra-adenylate. The binding of ligand results in a conformational change comprising the rotation of individual monomers relative to each other to form a more compact dimeric scaffold, in which a manganese cation coordinates the catalytic residues and activates the cleavage of single-stranded-but not double-stranded-nucleic acids (both DNA and RNA). In vivo, activation of Card1 induces dormancy of the infected hosts to provide immunity against phage infection and plasmids. Our results highlight the diversity of strategies used in CRISPR systems to provide immunity. Structural analyses of the type III CRISPR accessory protein Card1, which induces dormancy in infected hosts to provide immunity against phage infection, reveal the mechanisms by which it cleaves single-stranded RNA and DNA.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据